Caris Life Sciences, an AI-powered biotech and precision medicine company, has published a new study in JAMA Network Open titled, "An AI Approach to Differentiating Lung Squamous Cell Carcinoma From ...
The goal should be purposeful integration: using records to improve context for education, navigation, and appropriate escalation—without presenting the tool as a substitute for professional judgment.
ByteDance’s drug discovery unit Anew Labs presented its first AI-designed therapy at a major immunology conference in Boston, showing a generative-AI-designed small molecule targeting IL-17, a protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results